EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Validation of low-volume plasma dilution protocols for human cytomegalovirus DNA quantification using the cobas CMV assay

Gyujin Lim, Jun-Ho Kim, Ho-Joong Joo, Hee-Kyoung Jeon, Mi Ra Ryu iD, Sun Ae Yun, Areum Shin iD, Doo Ri Kim, Yae-Jean Kim, Tae Yeul Kim iD, Hee Jae Huh iD

Microbiology Spectrum · 2026

DOI: 10.1128/spectrum.01106-26 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Gyujin Lim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Cytomegalovirus, Cytomegalovirus Infections, DNA, Viral, Viral Load. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Health Industry Development Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Quantitative nucleic acid amplification tests (QNATs) for human cytomegalovirus (CMV) DNA are widely used for diagnosing and monitoring CMV infection. However, automated CMV-QNATs require relatively large plasma volumes, which may limit testing when specimen volume is limited, particularly in pediatric patients. Here, we evaluated the analytical and clinical performance of two plasma dilution protocols (1:2.5 and 1:5) for the cobas CMV assay to enable CMV DNA quantification using reduced plasma volumes. Analytical sensitivity and linearity were assessed using the World Health Organization International Standard for CMV, and precision was evaluated using pooled plasma. Clinical performance was evaluated using 135 plasma specimens by comparing results from diluted samples with those from the standard protocol. The estimated limits of detection for the 1:2.5 and 1:5 dilution protocols were 28.4 and 195.9 IU/mL, respectively, and the corresponding lower limits of quantitation were 200 and 1,000 IU/mL. Both protocols demonstrated acceptable linearity and excellent precision. Qualitative agreement with the standard protocol was high, with positive percent agreements of 97.9% and 94.7% and negative percent agreements of 95.0% and 100% for the 1:2.5 and 1:5 dilution protocols, respectively. Bland–Altman analysis showed minimal mean differences between diluted and undiluted measurements (−0.03 and −0.08 log 10 IU/mL). Although both dilution protocols showed agreement with the standard assay, the 1:2.5 dilution protocol demonstrated superior analytical sensitivity and a broader linear range. This protocol enables reliable CMV DNA quantification using as little as 200 μL of plasma and may facilitate CMV testing when plasma volume is limited. IMPORTANCE Automated quantitative nucleic acid amplification tests for human cytomegalovirus (CMV) DNA require relatively large plasma volumes, which can limit testing in pediatric patients and other settings with insufficient specimen volume. We evaluated 1:2.5 and 1:5 plasma dilution protocols for the cobas CMV assay using WHO International Standard materials and clinical plasma specimens. Both protocols showed strong agreement with the standard undiluted assay, while the 1:2.5 protocol provided better analytical sensitivity and enabled CMV DNA quantification using approximately 200 μL of plasma. Because no manufacturer-recommended plasma dilution protocol is available for this assay, these findings provide practical performance data that may support laboratories implementing low-volume CMV testing on widely used cobas 6800/8800 systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytomegalovirusCytomegalovirus InfectionsDNA, ViralViral LoadPlasmaNucleic Acid Amplification TechniquesHumansSensitivity and SpecificityReproducibility of Results

Stichwörter der Autor:innen

CMV DNA quantificationcobas 6800cytomegalovirusplasma dilutionviral load

Substanzen

DNA, Viral

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Center for Clinical Medicine, Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, South Korea.
  • Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, South Korea.

ORCID-Profile: Mi Ra Ryu, Areum Shin, Tae Yeul Kim, Hee Jae Huh

Förderung

  • Korea Health Industry Development Institute

Zitieren

APA

Lim, G., Kim, J. H., Joo, H. J., Jeon, H. K., Ryu, M. R., Yun, S. A., Shin, A., Kim, D. R., Kim, Y. J., Kim, T. Y., & Huh, H. J. (2026). Validation of low-volume plasma dilution protocols for human cytomegalovirus DNA quantification using the cobas CMV assay. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01106-26

Vancouver

Lim G, Kim JH, Joo HJ, Jeon HK, Ryu MR, Yun SA, et al. Validation of low-volume plasma dilution protocols for human cytomegalovirus DNA quantification using the cobas CMV assay. Microbiology Spectrum. 2026. doi:10.1128/spectrum.01106-26

BibTeX
@article{Lim2026,
  author = {Lim, Gyujin and Kim, Jun-Ho and Joo, Ho-Joong and Jeon, Hee-Kyoung and Ryu, Mi Ra and Yun, Sun Ae and Shin, Areum and Kim, Doo Ri and Kim, Yae-Jean and Kim, Tae Yeul and Huh, Hee Jae},
  title = {Validation of low-volume plasma dilution protocols for human cytomegalovirus DNA quantification using the cobas CMV assay},
  journal = {Microbiology Spectrum},
  year = {2026},
  doi = {10.1128/spectrum.01106-26}
}
Kostenlos starten →